A Phase IIb Study of AZD5462 in Patients with Chronic Heart Failure

Trial Identifier: D9090C00008
Sponsor: AstraZeneca
Start Date: June 2024
Primary Completion Date: November 2025
Study Completion Date: November 2025
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

No locations posted.